3 Results for "

ERK5-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ERK5-IN-2" in MCE Product Catalog:

Cat. No.: HY-128341
CAS No.: 1888305-96-1
Purity:  98.96%
Target:  

ERK

Research Areas:  

Cardiovascular Disease Cancer

ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. ERK5-IN-2 does not interact with the BRD4 bromodomain. ERK5-IN-2 suppresses both tumor xenograft growth and basic fibroblast growth factor (bFGF) driven Matrigel plug angiogenesis .
loading...
    loading...
Cat. No.: HY-173119
SKLB-D18 is an orally active ERK1/2/ERK5 inhibitor, with an IC50 of 38.69 nM and a Kd of 126.9 nM against human ERK1, an IC50 of 40.12 nM and a Kd of 209.8 nM against ERK2, and an IC50 of 59.72 nM and a Kd of 468.2 nM against ERK5. SKLB-D18 inhibits cancer cell proliferation, induces G0/G1 cell cycle arrest and apoptosis. SKLB-D18 reduces the levels of p-ERK5, p-RSKp90, p-c-Myc and c-Myc, and upregulates the level of p-ERK1/2, thereby inhibiting the ERK1/2/5 pathway in cells. SKLB-D18 increases LC3B-II accumulation, and decreases the levels of p62, p-mTOR and p-p70S6K. SKLB-D18 elevates the levels of ROS, lipid peroxidation and free ferrous ions, reduces the levels of NCOA4 and GPX4, and induces ferritin autophagy-dependent ferroptosis in cancer cells. SKLB-D18 exhibits antitumor activity in a triple-negative breast cancer xenograft mouse model. SKLB-D18 can be used in research related to triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-184975
CAS No.: 1234481-27-6
Research Areas:  

Cancer

ERK5 ligand-2 is an ERK5 ligand. ERK5 ligand-2 can serve as a ligand for the target protein in the synthesis of PROTAC ERK5 degraders, such as PPM-3 (HY-149616). ERK5 ligand-2 is suitable for use in cancer research .
loading...
    loading...